Exchange Transfusion in Neonates
What is Exchange Transfusion in Neonates?
Exchange transfusion in neonates is a medical procedure used to treat severe jaundice in newborn babies. During this procedure, small amounts of the baby's blood are removed and replaced with donor blood. This helps reduce dangerously high levels of bilirubin, a yellow substance that builds up when red blood cells break down too quickly.
The procedure is typically needed when a mother and baby have incompatible blood types. This incompatibility causes the mother's antibodies to attack the baby's red blood cells. As these cells break down, bilirubin levels rise rapidly. Without treatment, very high bilirubin can cause brain damage known as kernicterus.
Exchange transfusion is now less common than in the past thanks to better prevention and early treatment methods. However, it remains a critical intervention when phototherapy and other treatments fail to control severe hyperbilirubinemia. The procedure is performed in a neonatal intensive care unit by trained specialists.
Symptoms
- Yellow skin and eyes appearing within the first 24 hours after birth
- Dark yellow or orange skin color that worsens rapidly
- Poor feeding or difficulty waking the baby
- High-pitched crying or unusual irritability
- Arching of the body with the head thrown backward
- Low muscle tone or floppiness
- Seizures or abnormal eye movements
- Lethargy or extreme sleepiness
Some babies with mild jaundice may show few symptoms early on. However, severe cases requiring exchange transfusion typically develop symptoms quickly within the first day or two of life. Early recognition and treatment are essential to prevent permanent complications.
Concerned about Exchange Transfusion in Neonates? Check your levels.
Screen for 1,200+ health conditions
Causes and risk factors
The most common cause of severe neonatal jaundice requiring exchange transfusion is blood type incompatibility between mother and baby. ABO incompatibility occurs when a mother has type O blood and her baby has type A or B blood. Rh incompatibility happens when an Rh-negative mother carries an Rh-positive baby. In both cases, maternal antibodies cross the placenta and destroy the baby's red blood cells, causing rapid bilirubin buildup.
Risk factors include previous pregnancies with affected babies, lack of RhoGAM injections during pregnancy for Rh-negative mothers, premature birth, and certain genetic conditions affecting red blood cells. Babies with glucose-6-phosphate dehydrogenase deficiency or hereditary spherocytosis are at higher risk. Bruising during delivery, delayed bowel movements, and inadequate feeding can also contribute to severe jaundice in at-risk newborns.
How it's diagnosed
Diagnosis begins with a physical examination and measurement of bilirubin levels through blood tests or skin measurements. When bilirubin levels rise to dangerous ranges, typically above 20 to 25 milligrams per deciliter, exchange transfusion may be needed. Blood typing tests identify ABO and Rh factors in both mother and baby to determine if incompatibility is the cause.
A direct antibody test, also called a Coombs test, checks for maternal antibodies coating the baby's red blood cells. Additional tests may include a complete blood count and reticulocyte count to assess red blood cell destruction. Blood typing through ABO Blood Type and Rh Factor testing is available through Rite Aid's testing network at Quest Diagnostics locations. Early identification of incompatibility helps healthcare providers monitor at-risk newborns closely after birth.
Treatment options
- Exchange transfusion procedure performed in a neonatal intensive care unit
- Intensive phototherapy using special blue lights to break down bilirubin
- Intravenous immunoglobulin to reduce red blood cell destruction in incompatibility cases
- Frequent feeding to promote bowel movements and bilirubin elimination
- Careful monitoring of bilirubin levels every few hours
- Treatment of underlying causes such as infection or metabolic disorders
- RhoGAM injections during future pregnancies for Rh-negative mothers
- Follow-up developmental assessments to check for any complications
Need testing for Exchange Transfusion in Neonates? Add it to your panel.
- Simple blood draw at your nearest lab
- Results in days, not weeks
- Share results with your doctor
Frequently asked questions
Exchange transfusion is a procedure where a baby's blood is gradually removed and replaced with donor blood. It is needed when bilirubin levels become dangerously high due to severe jaundice, typically from blood type incompatibility. The procedure removes both excess bilirubin and the antibodies causing red blood cell destruction. It prevents brain damage that can occur when bilirubin reaches toxic levels.
Your baby may be at risk if you have type O blood and your baby has type A or B, or if you are Rh-negative and your baby is Rh-positive. Other risk factors include premature birth, family history of jaundice, bruising during delivery, and certain genetic conditions. Blood typing tests during pregnancy and at birth help identify incompatibility. Healthcare providers will monitor at-risk babies closely for signs of jaundice in the first days of life.
During the procedure, small amounts of the baby's blood are slowly removed through a catheter placed in an umbilical vessel. Donor blood is then infused to replace what was removed. The process is repeated multiple times over two to four hours until about twice the baby's blood volume has been exchanged. Medical staff continuously monitor vital signs throughout the procedure.
Jaundice from blood type incompatibility typically appears within the first 24 hours after birth. This is earlier than normal newborn jaundice, which usually starts on day two or three. The bilirubin level rises much faster in incompatibility cases. Babies at risk should have bilirubin levels checked within hours of birth and monitored closely during the first few days.
Many cases can be prevented through early identification and treatment. Rh-negative mothers receive RhoGAM injections during pregnancy and after delivery to prevent antibody formation. Early phototherapy can often control bilirubin levels before exchange transfusion becomes necessary. Blood typing tests during pregnancy help identify at-risk babies who need close monitoring. Prompt feeding and early detection of rising bilirubin levels allow for timely intervention.
Risks include changes in blood pressure, heart rate irregularities, blood clotting problems, infection, and electrolyte imbalances. Air bubbles in blood vessels and allergic reactions to donor blood are possible but rare. The catheter can occasionally cause bleeding or damage to blood vessels. Despite these risks, exchange transfusion is performed when the danger of untreated high bilirubin outweighs the procedural risks.
Most babies recover well within a few days after the procedure. Bilirubin levels are monitored closely for rebound hyperbilirubinemia, which can occur as antibodies continue destroying red blood cells. Many babies need continued phototherapy for several more days. Hospital stays typically last at least a week to ensure bilirubin levels remain stable and no complications develop.
Some babies require a second exchange transfusion if bilirubin levels rise again after the first procedure. This is more common in severe Rh incompatibility cases where maternal antibodies persist in the baby's bloodstream. Healthcare providers monitor bilirubin levels every few hours to determine if additional treatment is needed. Continued phototherapy and immunoglobulin therapy may prevent the need for repeat transfusions.
The donor blood type depends on the cause of jaundice. For ABO incompatibility, type O negative blood with low antibody levels is typically used. For Rh incompatibility, Rh-negative blood matching the baby's ABO type is chosen. The blood is also tested to ensure it lacks the antigens that would react with maternal antibodies. Blood typing tests help doctors select the safest donor blood for each baby.
Most babies who receive exchange transfusion develop normally without long-term problems when treated promptly. The main concern is preventing kernicterus, the brain damage caused by very high bilirubin. Babies who had severe jaundice should have developmental follow-up to check hearing, vision, and motor skills. Early treatment with exchange transfusion significantly reduces the risk of permanent complications.